RxSight, Inc. (RXST)
RXST Stock Price Chart
Explore RxSight, Inc. interactive price chart. Choose custom timeframes to analyze RXST price movements and trends.
RXST Company Profile
Discover essential business fundamentals and corporate details for RxSight, Inc. (RXST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Jul 2021
Employees
498.00
Website
https://www.rxsight.comCEO
Ronald Kurtz
Description
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
RXST Financial Timeline
Browse a chronological timeline of RxSight, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.21, while revenue estimate is $32.47m.
Earnings released on 6 May 2026
EPS came in at -$0.38 falling short of the estimated -$0.30 by -27.14%, while revenue for the quarter reached $30.89m , beating expectations by +3.84%.
Earnings released on 25 Feb 2026
EPS came in at -$0.22 surpassing the estimated -$0.33 by +34.27%, while revenue for the quarter reached $32.61m , beating expectations by +8.09%.
Earnings released on 5 Nov 2025
EPS came in at -$0.04 surpassing the estimated -$0.19 by +78.95%, while revenue for the quarter reached $30.34m , missing expectations by -6.94%.
Earnings released on 7 Aug 2025
EPS came in at -$0.08 surpassing the estimated -$0.10 by +20.00%, while revenue for the quarter reached $33.64m , beating expectations by +30.64%.
Earnings released on 7 May 2025
EPS came in at -$0.20 surpassing the estimated -$0.22 by +7.70%, while revenue for the quarter reached $37.90m , missing expectations by -0.49%.
Earnings released on 25 Feb 2025
EPS came in at $0.03 falling short of the estimated $0.10 by -70.00%, while revenue for the quarter reached $40.21m , beating expectations by +1.09%.
Earnings released on 7 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.25 by +36.00%, while revenue for the quarter reached $45.41m , beating expectations by +12.49%.
Earnings released on 5 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $34.89m , missing expectations by -0.44%.
Earnings released on 6 May 2024
EPS came in at -$0.12 surpassing the estimated -$0.17 by +29.41%, while revenue for the quarter reached $29.51m , beating expectations by +7.08%.
Earnings released on 28 Feb 2024
EPS came in at -$0.26 surpassing the estimated -$0.36 by +27.78%, while revenue for the quarter reached $28.58m , beating expectations by +4.19%.
Earnings released on 9 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.42 by +16.67%, while revenue for the quarter reached $30.67m , beating expectations by +19.05%.
Earnings released on 7 Aug 2023
EPS came in at -$0.40 surpassing the estimated -$0.47 by +14.89%, while revenue for the quarter reached $20.81m , beating expectations by +8.22%.
Earnings released on 9 May 2023
EPS came in at -$0.42 surpassing the estimated -$0.52 by +19.23%, while revenue for the quarter reached $17.49m , missing expectations by -9.05%.
Earnings released on 6 Mar 2023
EPS came in at -$0.56 surpassing the estimated -$0.72 by +22.22%, while revenue for the quarter reached $16.09m , missing expectations by -1.18%.
Earnings released on 7 Nov 2022
EPS came in at -$0.61 surpassing the estimated -$0.70 by +12.86%, while revenue for the quarter reached $12.62m , beating expectations by +14.91%.
Earnings released on 8 Aug 2022
EPS came in at -$0.50 surpassing the estimated -$0.68 by +26.47%, while revenue for the quarter reached $11.36m , beating expectations by +7.68%.
Earnings released on 5 May 2022
EPS came in at -$0.54 surpassing the estimated -$0.56 by +3.57%, while revenue for the quarter reached $8.94m , beating expectations by +22.17%.
Earnings released on 8 Mar 2022
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%, while revenue for the quarter reached $8.43m , beating expectations by +10.30%.
Earnings released on 10 Nov 2021
EPS came in at -$0.65 falling short of the estimated -$0.61 by -6.56%, while revenue for the quarter reached $5.79m , beating expectations by +5.88%.
Earnings released on 9 Sept 2021
EPS came in at -$3.24 falling short of the estimated -$0.68 by -376.47%, while revenue for the quarter reached $4.90m .
Earnings released on 30 Jul 2021
EPS came in at -$0.36 , while revenue for the quarter reached $3.48m .
RXST Stock Performance
Access detailed RXST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
